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PRECLINICAL STUDIES
nvolvement of the Nicotinamide
denosine Dinucleotide Phosphate
xidase Isoform Nox2 in Cardiac Contractile
ysfunction Occurring in Response to Pressure Overload
avid J. Grieve, PHD, Jonathan A. Byrne, PHD, MRCP, Anjana Siva, PHD, MRCP, Joanne Layland, PHD,
ofian Johar, MRCP, Alison C. Cave, PHD, Ajay M. Shah, MD, FAHA
ondon, England
OBJECTIVES This study sought to examine the role of Nox2 in the contractile dysfunction associated with
pressure-overload left ventricular hypertrophy (LVH).
BACKGROUND Reactive oxygen species (ROS) production is implicated in the pathophysiology of LVH. The
nicotinamide adenosine dinucleotide phosphate oxidase isoform, Nox2, is pivotally involved
in angiotensin II-induced hypertrophy but is not essential for development of pressure-
overload LVH. Its possible impact on contractile function is unknown.
METHODS The effects of aortic banding or sham surgery on cardiac contractile function and interstitial
fibrosis were compared in adult Nox2/ and matched wild-type (WT) mice.
RESULTS Banding induced similar increases in left ventricular (LV) mass in both groups. Banded
Nox2/ mice had better LV function than WT by echocardiography (e.g., fractional
shortening 33.6  2.5% vs. 21.4  2.2%, p  0.05). Comprehensive LV pressure-volume
analyses also showed significant contractile dysfunction in banded WT compared with sham,
whereas bandedNox2/mice had preserved function (e.g., maximum rate of rise of LV pressure:
banded WT, 4,879  213; vs. banded Nox2/, 5,913  259 mm Hg/s; p  0.05). Similar
preservation of function was observed in isolated cardiomyocytes. The 24-h to 36-h treatment
of banded WT mice with N-acetylcysteine resulted in recovery of contractile function.
Cardiac interstitial fibrosis was significantly increased in banded WT but not Nox2/ mice,
together with greater increases in procollagen I and III mRNA expression.
CONCLUSIONS The Nox2 oxidase contributes to the development of cardiac contractile dysfunction and
interstitial fibrosis during pressure overload, although it is not essential for development of
morphologic hypertrophy per se. These data suggest divergent downstream effects of Nox2 on
different components of the overall response to pressure overload. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.05147:817–26) © 2006 by the American College of Cardiology Foundation
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gn increase in oxidative stress is implicated in the patho-
hysiology of left ventricular hypertrophy (LVH) (1). In-
reased reactive oxygen species (ROS) production occurs
oth in experimental models of cardiomyocyte hypertrophy
nd with in vivo pressure-overload LVH, whereas antioxi-
ants may exert beneficial effects in experimental in vivo
VH and heart failure (2–6). The ROS influence LVH
athophysiology through several mechanisms. Increased
OS production contributes to development of cardiomy-
cyte hypertrophy induced by G-protein–coupled receptor
gonists, cytokines, and mechanical stretch, at least in part
hrough activation of redox-sensitive protein kinases and
ranscription factors (3–6). Oxidative stress promotes myo-
yte apoptosis and necrosis, especially in advanced hyper-
rophy and heart failure (1,3,7). The ROS may also alter
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005, accepted September 19, 2005.ardiac contractile properties, for example by modulating
he function of sarcolemmal ion channels/exchangers, sar-
oplasmic reticular proteins, myofilaments, and/or enzymes
nvolved in energy metabolism (8–10). Finally, ROS con-
ribute to endothelial dysfunction through inactivation of
itric oxide, and also promote interstitial fibrosis and extra-
ellular matrix remodeling (1,11).
Given these effects of oxidative stress, elucidation of the
oles of different ROS sources (e.g., mitochondria, xanthine
xidase, uncoupled nitric oxide synthases) is important. In
his regard, recent studies from several laboratories, including
ur own, have addressed the potential involvement of nicotin-
mide adenosine dinucleotide phosphate (NADPH) oxidases
n LVH pathophysiology. These superoxide-generating en-
ymes are major cardiovascular ROS sources, particularly in the
asculature, where they play important roles in hypertension,
therosclerosis, angiogenesis, and other conditions (12). The
rototypic NADPH oxidase (first characterized in neutrophils)
omprises a membrane-bound heterodimer consisting of one
p91phox (or Nox2) and one p22phox subunit, and several
egulatory subunits (p47phox, p67phox, p40phox, and Rac) that
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Nox2 and Contractile Dysfunction in LVH February 21, 2006:817–26ssociate with the heterodimer in the activated enzyme
omplex (12,13). The Nox subunit is the catalytic core of
he oxidase and, recently, several isoforms (Nox1 to 5) were
dentified that have specific tissue distributions and may
ubserve distinct (patho)physiological functions (13). The
ajor isoforms expressed in heart seem to be Nox2 and
ox4, with the Nox2 oxidase found in cardiomyocytes,
broblasts, and endothelial cells (12,14–16).
The NADPH oxidases are implicated in cardiomyocyte
ypertrophic signaling in response to angiotensin II (AngII)
r alpha-adrenergic agonists (16,17), whereas Rac1 (which
s involved in oxidase activation) induces cardiomyocyte
ypertrophy (18,19). Increased cardiac NADPH oxidase
xpression and activity was shown in experimental pressure-
verload LVH, with evidence that ROS derived from the
xidase may contribute to contractile dysfunction in this
etting (14,20,21). Similarly, increased NADPH oxidase
igure 1. Effect of pressure overload on cardiac fibrosis. (A) Interstitial co
Abbreviations and Acronyms
ANF  atrial natriuretic factor
AngII  angiotensin II
EDPVR  end-diastolic pressure volume relation
ESPVR  end-systolic pressure volume relation
IVSD  interventricular septal thickness in diastole
LVEDD  left ventricular end-diastolic dimension
LVESD  left ventricular end-systolic dimension
LVH  left ventricular hypertrophy
NADPH  nicotinamide adenosine dinucleotide
phosphate, reduced
ROS  reactive oxygen species
WT  wild-typeB to D) messenger ribonuclerc acid expression of procollagen I, procollagen III,
orresponding sham; †p  0.05 versus banded Nox2/. WT  wild type.ctivity was also documented in failing human hearts
22,23). Recently, we began to specifically investigate the
ole of the Nox2 oxidase in the development of cardiac
ypertrophy (15,24). In Nox2-deficient mice (Nox2/)
25), LVH induced by short-term subpressor AngII infu-
ion was substantially inhibited together with abolition of
ngII-induced NADPH oxidase activation (24). In marked
ontrast, increases in LV mass and myocyte size during
ressure overload induced by aortic banding were similar in
ox2/ and wild-type (WT) mice, indicating that Nox2 is
ot essential for development of pressure-overload LVH
15). The latter findings were confirmed by Maytin et al.
26). Because ROS potentially affect several aspects of
ardiac structure and function, however, these studies do not
ddress the role of Nox2 in other components of the overall
esponse to pressure overload. In the present study, we
xamined the role of Nox2 in the contractile dysfunction
nd fibrosis associated with pressure-overload LVH.
ETHODS
xperimental LVH. Adult male Nox2/ and matched
T littermate controls underwent suprarenal abdominal
ortic banding or sham surgery (15). Banding caused similar
ncreases in invasively measured systolic blood pressure in WT
sham, 90  3 mm Hg; banded, 135  5 mm Hg) and
ox2/ mice (sham, 86 3 mm Hg; banded, 130 8 mm
g). Some animals were pretreated with N-acetylcysteine (500
g/kg/day in drinking water) for 24 to 36 h before being
illed. All procedures were performed in accordance with
n assessed in left ventricular (LV) sections stained with Picrosirius red.llage
and fibronectin. Data are mean SEM from six animals. *p 0.05 versus
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February 21, 2006:817–26 Nox2 and Contractile Dysfunction in LVHhe Guidance on the Operation of the Animals (Scientific
rocedures) Act, 1986 (United Kingdom).
istology. Interstitial fibrosis was assessed in frozen LV
ections (6 m) by Picrosirius red staining. Blinded quan-
itative image analysis (Openlab, Improvision, Coventry,
nited Kingdom), excluding coronary vessels and perivas-
ular regions, was undertaken (27). Immunohistochemistry
or 3-nitrotyrosine (28) was performed with a rabbit poly-
lonal antibody (Upstate Biotechnology, Dundee, United
ingdom; 1:1,000), using diaminobenzidine for final visu-
lization and counterstaining with nuclear fast red (Dako-
ytomation, Glostrup, Denmark). Non-immune rabbit im-
unoglobulin G was used as a negative control.
eal-time reverse transcriptase-polymerase chain reaction.
xpression of atrial natriuretic factor (ANF), procollagen I/III,
nd fibronectin mRNA were analyzed by real-time reverse
ranscriptase-polymerase chain reaction with fluorescent
YBR Green technology on a Prism 7000 HT system
Applied Biosystems, Warrington, United Kingdom), using
lyceraldehyde-3-phosphate dehydrogenase mRNA for
ormalization (15). The primers were (5= to 3=):
lyceraldehyde-3-phosphate dehydrogenase forward CGT-
CCGCCTGGAGAA, reverse CCCTCAGATGCCT-
CTTCAC; ANF forward CGTGCCCCGACCCA-
GCCAGCATGGGCTCC, reverse GGCTCCGAGGG-
CAGCGAGCAGAGCCCTCA; procollagen I1 forward
CTCAGGGTATTGCTGGACAAC, reverse TTGAT-
CAGAAGGACCTTGTTTG; procollagen III1 forward
GGAGCCAGTGGCCATAATG, reverse TGACCAT-
TGATCCAGGGTTTC; fibronectin forward CCGGTG-
CTGTCAGTCAGA, reverse CCGTTCCCACTGCT-
ATTTATC. The comparative Ct method was used for
elative quantification, with validation experiments showing
pproximately equal efficiencies of primers. All samples were
un in triplicate, and data were expressed in arbitrary units.
chocardiography. Mice were anesthetized with 1% to
.5% isoflurane/oxygen and placed on a warming pad.
mages were acquired using a Sonos 5500 system with a 15
Hz linear probe (Philips, Bothell, Washington). Two-
imensional LV short-axis views were acquired at the
apillary muscle level, and M-mode recordings were made.
epth settings were adjusted to maximize frame rate (220
o 260 Hz) and optimize temporal resolution. The inter-
entricular septal thickness in diastole (IVSD) and the left
entricular end-diastolic and end-systolic dimensions
Table 1. Echocardiographic Parameters in Sha
Sham WT Ban
Heart rate (beats/min) 431  18 451
IVSD (mm) 0.77  0.02 1.13
LVEDD (mm) 3.92  0.05 3.82
LVESD (mm) 2.48  0.10 3.01
FS (%) 36.9  2.4 21.4
Data are mean  SEM from 8 to 10 animals. *p  0.05 ve
FS  fractional shortening; IVSD  interventricular septal thi
dimension; LVESD  left ventricular end-systolic dimension; WTLVEDD and LVESD, respectively) were measured using
hree consecutive cycles.
V pressure-volume analyses. Left ventricular function
as analyzed in isolated ejecting hearts under controlled
oading and heart rate of 450 bpm (29,30). A custom 1.4-F
icroconductance catheter (SPR-853; Millar Instruments,
ouston, Texas) was inserted into the LV apex for mea-
urement of volume and high-fidelity pressure. Atrial inflow
nd aortic outflow were measured by ultrasonic transit
robes (1N; Transonic Systems, Ithaca, New York). Left
trial filling pressure (preload) was varied from 10 to 25 cm
2O to generate Starling curves. The LV pressure-volume
elationships were also studied during transient occlusion of
he aortic outflow tract, and end-systolic and end-diastolic
ressure-volume relations (ESPVR and EDPVR, respec-
ively) were determined. Absolute volume measurements
ere corrected for alpha and parallel conductance (30,31).
ardiomyocytes. Ventricular myocytes were isolated by
ollagenase digestion, and single myocyte shortening was
uantified (29).
tatistics. Between 5 and 10 animals per group were studied
or all protocols. Data were analyzed by two-way repeated
easures ANOVA, one-way ANOVA, or an unpaired Stu-
ent’s t test, as appropriate. p  0.05 was considered
ignificant.
ESULTS
evelopment of LVH. Consistent with our previous study
15), two weeks of pressure overload caused similar increases
n the LV:body weight ratio in banded WT (4.57  0.29
g/g vs. 3.21  0.07 mg/g, p  0.05) and Nox2/ (4.87 
.18 mg/g vs. 3.40  0.07 mg/g, p  0.05) versus shams.
trial, right ventricular, lung, and body weights were similar
etween groups. The ANF mRNA expression increased to
similar extent in banded WT and Nox2/ versus sham
WT, 16.7 2.1 arbitrary units vs. 2.3 0.1 arbitrary units;
ox2/, 19.3  3.6 arbitrary units vs. 2.9  1.5 arbitrary
nits, p  0.05).
nterstitial fibrosis. After 2 weeks, interstitial fibrosis in-
reased significantly in banded WT mice compared with
ham (63  11%, p  0.05) but no significant change
ccurred in banded Nox2/ mice (Fig. 1A). Procollagen I
nd III mRNA were also significantly increased in banded WT
ice (Figs. 1B and 1C). In contrast, no significant increase in
rocollagen ImRNAoccurred in bandedNox2/mice, whereas
perated and Banded WT and Nox2/ Mice
T Sham Nox2/ Banded Nox2/
411  11 437  17
04* 0.75  0.04 1.06  0.02*
08 3.94  0.15 3.93  0.08
12* 2.64  0.19 2.61  0.10
2* 33.6  3.1 33.6  2.5
propriate sham control.m-O
ded W
 18
 0.
 0.
 0.
 2.
rsus ap
ckness in diastole; LVEDD  left ventricular end-diastolic
 wild-type.
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Nox2 and Contractile Dysfunction in LVH February 21, 2006:817–26he increase in procollagen IIImRNAwas significantly lower than
n bandedWT. FibronectinmRNAdid not increase in any group
Fig. 1D).
chocardiography. Consistent with the morphometric
ata, banded WT and Nox2/ mice showed similar
ncreases in IVSD after two weeks (Table 1). Fractional
hortening was significantly reduced in banded WT mice
ompared with sham, with a significant increase in LVESD.
igure 2. Left ventricular (LV) function in isolated ejecting hearts from w
able 2. Hemodynamic Parameters in Sham-Operated and Band
Sham WT
F (ml min1 g1) 44.8  6.2
VPmax (mm Hg) 84.3  1.1
VESP (mm Hg) 52.2  0.7
VEDP (mm Hg) 4.5  0.4
VdP/dtmax (mm Hg s
1) 5,757  178
VdP/dtmin (mm Hg s
1) 3,576  135 
au (ms) 8.0  0.3
VESV (l) 20.2  1.6
VEDV (l) 47.7  2.4
troke volume (l) 27.5  1.1
jection fraction (%) 58.0  1.5
W (mm Hg·l g1) 18,925  1,263 1
SPVR 4.81  0.36
DPVR 0.065  0.004
teady-state cardiac function was assessed at 20-cm pre-load. Data are mean  SEM
CF  coronary flow; EDPVR  end-diastolic pressure-volume relation; ESPVR
V end-diastolic volume; LVESP LV end-systolic pressure; LVESV LV end-systolEDV). Changes in A and D: maximum rate of rise of LV pressure (LVdP/dtmax
hanges in C and F: stroke work (SW). Data are mean  SEM from eight ann contrast, neither LVESD nor fractional shortening were
ignificantly altered in banded Nox2/ mice. Heart rate
nd LVEDD were similar among groups.
V pressure-volume analyses. Table 2 shows parameters
f steady-state cardiac function in WT and Nox2/ mice,
tudied two weeks after surgery. Banded WT mice showed
ignificant reductions in LVdP/dtmax, end-systolic pressure,
nd ejection fraction, and an increase in end-systolic volume
pe (WT) and Nox2/ mice across a range of LV end-diastolic volumes
T and Nox2/ Mice
ed WT Sham Nox2/ Banded Nox2/
 3.3 56.8  5.4 49.5  5.0
 1.2 86.1  1.5 87.2  2.0
 1.3* 51.3  1.3 51.0  0.7
 1.0 7.6  1.1 7.8  0.5
 213* 5,733  169 5,913  259
 179* 3,474  116 3,273  169
 0.5* 8.8  0.5 9.2  0.7
 3.1* 21.9  1.4 23.4  1.6
 4.1 49.5  1.9 53.8  2.2
 1.4 27.7  0.8 30.4  1.4
 2.0* 56.1  1.3 56.7  2.1
 977* 19,057  1,029 17,741  1,520
 0.36* 4.74  0.30 4.67  0.15
 0.006* 0.080  0.005 0.087  0.005
eight animals. *p  0.05 versus appropriate sham control.
-systolic pressure-volume relation; LVEDP  LV end-diastolic pressure; LVEDV 
me; LVPmaxmaximum LV systolic pressure; SW stroke work; WT wild-type.ild-tyed W
Band
40.3
81.4
48.6
5.9
4,879
3,041
9.6
28.8
53.8
25.1
47.3
2,844
3.68
0.087
from); changes in B and E: maximum rate of fall of LV pressure (LVdP/dtmin);
imals. *p  0.05 banded (solid squares) versus sham (open squares).
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February 21, 2006:817–26 Nox2 and Contractile Dysfunction in LVHompared with sham, indicating impaired systolic function.
VdP/dtmin was also significantly reduced, and isovolumic
elaxation time-constant (Tau) increased in banded WT
ice, indicating impaired relaxation. None of these param-
ters were significantly altered in banded Nox2/ mice.
Figure 2 shows LVdP/dtmax, LVdP/dtmin, and stroke
ork measured across a range of LV volumes and confirms
ignificant reductions in these parameters in banded WT
ice but preservation of function in banded Nox2/ mice.
he differences in stroke work between WT and Nox2/
ice are further appreciated from the representative LV
ressure-volume loops shown in Figures 3A and 3D, in
hich stroke work is the area of the loop.
Figure 3 shows representative examples of data obtained
uring transient aortic occlusion. The slope of the ESPVR
as significantly decreased in banded WT mice, indicating
educed contractility, but was unaltered in banded Nox2/
ice (Figs. 3B and 3E). The slope of the EDPVR was signifi-
antly increased in banded WT mice, indicating increased dia-
tolic stiffness, but was unaltered in banded Nox2/mice (Figs.
C and 3E). Mean data are shown in Table 2.
ardiomyocyte function. To assess whether differences in
ontractile function found at the whole-heart level were also
resent at the cellular level, we studied isolated cardiomyo-
ytes. Myocytes from banded WT mice had significantly
igure 3. Representative examples of left ventricular (LV) pressure-volume
WT) and Nox2/ mice. (A and D) Steady-state pressure-volume loops
ressure volume relation (EDPVR).educed twitch shortening (by 20%) compared with sham sFigs. 4A and 4C). In contrast, the shortening of myocytes
rom banded Nox2/ mice was non-significantly reduced
Figs. 4B and 4D).
ffect of N-acetylcysteine. Treatment with the antioxi-
ant N-acetylcysteine for 36 h before killing at the two-
eek post-surgical time point resulted in normalization of
chocardiographic fractional shortening and LVESD in
anded WT mice (Figs. 5A and 5C); heart rate, IVSD, and
VEDD (Fig. 5B) were unaffected. N-acetylcysteine also
ncreased LVdP/dtmax, stroke work, ESPVR (Figs. 5D to
F), ejection fraction, and LVdP/dtmin (data not shown) in
solated ejecting hearts of banded WT mice. Furthermore,
n vivo N-acetylcysteine treatment for 24 h significantly
mproved contraction of cardiomyocytes isolated from
anded WT hearts (e.g., shortening velocity, untreated,
2.0  0.07 ms1; treated, 2.9  0.16 ms1; p 
.05), but had minimal effects in the sham group (untreated,
2.4  0.07 ms1, treated, 2.6  0.11 ms1; p 
S). A similar improvement of contractility was found with
ddition of N-acetylcysteine to isolated hearts or myocytes
or 15 to 20 min, but this effect did not stabilize over this
ime period (i.e., continued to increase).
To assess whether the effects of N-acetylcysteine were
ttributable to reduced oxidative stress, we assessed
-nitrotyrosine staining in LV sections. Banded WT hearts
ses in banded (solid squares) and sham-operated (open squares) wild-type
nd E) End-systolic pressure relation (ESPVR). (C and F) End-diastolicanalyhowed increased 3-nitrotyrosine staining, but this was
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Nox2 and Contractile Dysfunction in LVH February 21, 2006:817–26ignificantly reduced in hearts from banded animals treated
ith N-acetylcysteine for 36 h (Fig. 6).
ontractile function after eight weeks of pressure overload.
o assess whether the differences in contractile function
etween WT and Nox2/ mice persisted after longer
urations of pressure overload, animals were studied at eight
eeks after surgery. Figure 7 shows cardiac functional param-
igure 4. Effect of pressure overload on cell shortening (CS) in cardiomyoc
f myocyte contraction. (C and D) Mean  SEM from 60 cells from fo
ersus sham.igure 5. Effect of N-acetylcysteine on cardiac function assessed (A to C) by echoca
nimals; darker columns  N-acetylcysteine-treated animals. Data are mean ters measured in isolated ejecting hearts. Banded WT mice
howed substantial reductions in LVdP/dtmax, LVdP/dtmin,
nd cardiac work compared with shams, which were greater
han those observed after two weeks (Fig. 3). Banded Nox2/
ice now also showed significant reductions in LVdP/dtmax,
VdP/dtmin, and cardiac work, but the degree of impairment
emained much less than in banded WT mice.
rom wild-type (WT) and Nox2/ mice. (A and B) Representative traces
rts. Dark columns  banded mice; lighter columns  shams. *p  0.05ytes frdiography and (D to F) in isolated ejecting hearts. Light columns control
SEM from eight animals. *p  0.05 versus corresponding control.
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February 21, 2006:817–26 Nox2 and Contractile Dysfunction in LVHISCUSSION
he major novel finding of this study is that the Nox2
ADPH oxidase contributes to development of cardiac
ontractile dysfunction and interstitial fibrosis in response to
ressure overload, even though it is not essential for devel-
pment of LVH per se. The Nox2 oxidase therefore
nfluences specific components of the overall response to
ressure overload, indicating that related but distinct com-
onents of the overall cardiac hypertrophic phenotype may
e subject to independent regulation.
Oxidative stress is recognized to be involved in LVH
athophysiology, but the precise roles of different ROS
ources remains unclear (1–6). Furthermore, the possibility
f divergent effects on contractile function or interstitial
brosis as opposed to increases in LV mass has not been
idely addressed. Recent work suggests a role for NADPH
xidases in the development of cardiac hypertrophy and
nterstitial fibrosis (14,21,24). A relatively unique attribute
igure 6. Representative left ventricular (LV) sections from wild-type (WT
C) N-acetylcysteine-treated sham; (D) N-acetylcysteine-treated banded.f NADPH oxidases in contrast to other ROS sources (e.g., Nitochondria, xanthine oxidase) is that ROS generation in
esponse to specific stimuli and subsequent modulation of
ownstream signal transduction seems to be a primary
unction of these enzymes (12,13). In addition, the presence
f at least two cardiac Nox isoforms (Nox2 and Nox4) raises
he possibility of not only stimulus-specific but also isoform-
pecific roles (12,13,15). Our previous findings that LVH
nduced by subpressor AngII was inhibited in Nox2/
ice (24) indicated that Nox2-derived ROS are specifically
nvolved in cardiac AngII signaling. Consistent with this,
ngII-induced cardiac hypertrophy and fibrosis were inhib-
ted in mice lacking apoptosis signal-regulating kinase 1,
hich is known to be redox-sensitive (32). However,
ox2/ mice developed a similar degree of LVH to WT
nimals in response to pressure overload (15,26), indicating
hat even though Nox2 mediates hypertrophy in response to
ngII, other pathways may be more important or may
ubstitute for Nox2 when the stimulus is pressure overload.
e stained for 3-nitrotyrosine (20 magnification). (A) Sham, (B) banded;evertheless, the current study shows that Nox2 plays a
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Nox2 and Contractile Dysfunction in LVH February 21, 2006:817–26ajor role in the development of interstitial fibrosis and
ontractile dysfunction in response to pressure overload.
nterestingly, pressure overload was found to increase
ADPH oxidase activity and ROS production even in
ox2/ mice, secondary to upregulation of Nox4 in these
nimals (15). This finding, together with the results of the
resent study, indicates that the downstream effects of Nox2
uring pressure overload are highly specific; i.e., neither
ox4 nor other ROS sources apparently promotes fibrosis
r contractile dysfunction in Nox2/ mice.
Previous seminal studies have established that although
ardiomyocyte hypertrophy and interstitial fibrosis often
o-exist, they are to a significant extent independently
egulated (33). Oxidative stress is pro-fibrotic both in the
eart and in other organs, by stimulating fibroblast prolif-
ration, collagen deposition, and activation of matrix met-
lloproteinases (1,33–35). The novel finding of the current
tudy is the demonstration of a specific role for the Nox2
xidase in promoting interstitial cardiac fibrosis during pres-
ure overload. Inhibition of interstitial fibrosis in banded
ox2/ mice was shown both by histology and real-time
everse transcriptase-polymerase chain reaction. Taken to-
ether with previous data indicating an involvement of
ox2 in AngII-induced cardiac, vascular, and hepatic fibro-
is (24,28,36), these results may suggest a broader role of
igure 7. Left ventricular (LV) function in isolated ejecting hearts from wild
VdP/dtmax; (B and E) LVdP/dtmin; and (C and F) cardiac work (CW). D
ersus sham (open squares).ox2 in mediating pathological fibrosis. wThe other major effect of Nox2 was found to be in the
evelopment of contractile dysfunction during pressure
verload. We undertook detailed characterization of con-
ractile function by both echocardiography in vivo and LV
ressure-volume analyses in isolated ejecting hearts. The
T mice had significant systolic dysfunction after two
eeks of pressure overload as evidenced by reduced echo-
ardiographic fractional shortening, increased LVESD, and
eduction in pressure (LVdP/dtmax) and volume-based in-
ices (LV end-systolic volume and ejection fraction) as well
s the slope of the ESPVR. Banded WT mice also had
mpaired relaxation (reduced LVdP/dtmin, prolonged tau)
nd evidence of diastolic dysfunction (increased slope of
DPVR). In marked contrast, none of these parameters
ere significantly altered in banded Nox2/ mice. Fur-
hermore, brief (24-h to 36-h) treatment with the antioxi-
ant N-acetylcysteine improved contractile function and
educed LV 3-nitrotyrosine staining in WT bands, suggest-
ng that the dysfunction was indeed mediated via ROS.
hereas we previously showed that chronic (two-week)
reatment with N-acetylcysteine inhibited the development
f pressure-overload hypertrophy (15), the current brief
24-h to 36-h) protocol was specifically chosen to investi-
ate effects on contractile function independent of hyper-
rophy. With more prolonged pressure overload (eight
(WT) and Nox2/ mice eight weeks after surgery. Changes in (A and D):
e mean SEM from five to six animals. *p 0.05 banded (solid squares)-type
ata areeks), we found that contractile dysfunction did develop in
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February 21, 2006:817–26 Nox2 and Contractile Dysfunction in LVHox2/ mice but the magnitude of dysfunction remained
ess than with banded WT. These data suggest that Nox2
ay be particularly important for contractile dysfunction in
he early stages of pressure overload. With more prolonged
verload, it is likely that other mechanisms, such as ROS-
ndependent abnormalities of excitation-contraction cou-
ling and energetic deficit, may also become relevant (37).
ur results contrast with a recently published study in
hich no differences in cardiac function were found be-
ween Nox2/ and WT mice subjected to aortic constric-
ion (26). However, in that study, the pressure overload was
robably much more severe than in the present study
ecause it resulted in 50% LVH after just one week and
50% mortality, compared with 20% mortality in our
tudy. These data leave open the possibility that the contri-
ution of Nox2 to contractile dysfunction during pressure
verload may depend on the degree of overload, a question
hat warrants further investigation.
Increased ROS production may lead to contractile dys-
unction through several mechanisms, including alterations
n cellular energetics, changes in excitation-contraction
oupling, and/or alterations in myofilament calcium respon-
iveness (1,8–10,38). At the whole-heart level, contractile
unction may also be influenced by alterations in the
xtracellular matrix (11). In the current study, we found
ignificant differences in function of cardiomyocytes isolated
rom banded Nox2/ and WT, suggesting that a signifi-
ant proportion of the contractile dysfunction in whole
earts may be attributable to intrinsic myocyte dysfunction.
owever, the differences in diastolic properties observed
etween banded Nox2/ and WT may be related to the
bserved changes in interstitial fibrosis. The precise mech-
nisms underlying Nox2-dependent contractile dysfunction
equire further investigation, but our preliminary studies do
ot show significant differences in expression of SERCA2a
r phospholamban between banded Nox2/ and WT
data not shown).
In summary, this study shows that the Nox2 NADPH
xidase specifically contributes to the development of both
ontractile dysfunction and interstitial fibrosis in response to
ressure overload, despite not being essential for the devel-
pment of LVH per se. This divergent regulation of LV
ypertrophy and LV function is analogous to a number of
ther recent reports of experimental models in which these
spects of cardiac hypertrophy have been found to be
ndependently regulated, e.g., by the PI3K-PTEN pathway
39,40) and the MEKK1-JNK pathway (41). Also analo-
ous to these reports, the Nox2 oxidase in the heart not only
eems to be activated in an isoform-specific manner, but also
xerts isoform-specific downstream effects on distinct com-
onents of the overall cardiac hypertrophic phenotype.
hese data underscore the likely importance of independent
edox regulation of different aspects of the cardiac response
o pressure overload.eprint requests and correspondence: Dr. Ajay M. Shah, De-
artment of Cardiology, GKT School of Medicine, Bessemer
oad, London SE5 9PJ England. E-mail: ajay.shah@kcl.ac.uk.
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